Vasomotor symptoms (VMS) including hot flashes are a common complaint among men undergoing androgen deprivation therapy (ADT) for prostate cancer. Although the symptoms are more widely associated with ...
AOL: Study Finds Promising Relief for Hot Flashes in Men with Prostate Cancer
Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and sweating. It can feel like a panic attack for some people before the heat ...
Study Finds Promising Relief for Hot Flashes in Men with Prostate Cancer
Among men with prostate cancer receiving androgen deprivation therapy (ADT), oxybutynin led to significant reductions in hot flash frequency, with the 5-mg twice-daily dose decreasing hot flashes by ...
A phase 2 randomized, double-blind trial tested oxybutynin 2.5 mg BID and 5 mg BID versus placebo for six weeks in men on stable ADT with ≥28 weekly hot flashes. Dose-dependent efficacy was observed, ...
Men receiving placebo experienced an average reduction of 2.15 hot flashes per day and a 4.85‑point drop in daily hot flash severity scores, whereas those taking 2.5 mg of oxybutynin twice daily ...
The Vindicator: The People’s Pharmacy: Low T could be the cause of hot flashes in men
The People’s Pharmacy: Low T could be the cause of hot flashes in men
EurekAlert!: Randomized trial finds drug therapy reduces hot flashes during prostate cancer treatment
Randomized trial finds drug therapy reduces hot flashes during prostate cancer treatment
Healio: ‘Clearly beneficial’: Oxybutynin reduces hot flashes for men with prostate cancer
MSN: Study finds promising relief for hot flashes in men with prostate cancer